A final exam in treating the human condition for nursing students
7th Beauty in Biology 2017-2018 Competition
Eligibility: LUC undergraduate or graduate students in any major, as well as alumni.
Submission deadline: April 2nd, 2018*
1st Prize: $1000.00
Collaboration between science majors and artists is encouraged
Click BnB 2017-2018 Contest Info for full contest details
*Please email Prof. Bill Rochlin, firstname.lastname@example.org, and provide an estimate of the anticipated size of your work by March 1, 2018 (earlier is better).
Units of Life (partial)
Winner, 6th BnB competition, April 2017
Frontiers in Science Symposium
Dr. John Dye Presents
FLIPPING YOUR MINDSET: An Ebola Inspired Tale
Wed., March 21, 4:30-5:30pm
Sullivan Center - Galvin Auditorium
As the Chief of Viral Immunology within the Virology Division at USAMRIID, Dr. Dye oversees the execution of research programs in medical countermeasures against viral biological warfare agents in a high-hazard, multi-suite, biocontainment laboratory that operates at Biosafety Levels 2, 3, and 4. Dr. Dye’s research focuses on filovirus vaccines and therapeutics, with the ultimate aim to counteract the Ebola virus and other high risk pathogens. Dr. Dye is on the cutting edge of research and development of medical countermeasures against filoviruses (e.g., Ebola virus, Sudan virus, and Marburg virus) and other biological threat agents. Since 2012, Dr. Dye has been traveling to Uganda to track the immune response in over 200 survivors of Ebola virus disease. Specifically, he assesses the immune responses of these survivors over time in hopes of determining an “immune profile” to drive vaccine and therapeutic development for the future. His extensive network of research collaborators has influenced basic science research on various aspects of virology and immunology, including the identification and publication of filovirus and Lassa virus receptors in the journals Nature and Science, respectively. These findings have driven protein-specific medical countermeasures against both viruses in order to provide a treatment option.